Clinical Trials Logo

Vancomycin Resistance clinical trials

View clinical trials related to Vancomycin Resistance.

Filter by:
  • None
  • Page 1

NCT ID: NCT00079976 Completed - Clinical trials for Gram-Positive Bacterial Infections

Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)

Start date: October 2003
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of tigecycline in the treatment of selected serious infections caused by VRE. The primary efficacy endpoint will be the clinical response for all subjects.